Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.

导出原文传递

翻译打印收藏纠错

第一作者： Haruhiro,Saito

第一单位： Kanagawa Cancer Center, Yokohama, Japan.

作者： Haruhiro,Saito ^[1] ; Tatsuro,Fukuhara ^[2] ; Naoki,Furuya ^[3] ; Kana,Watanabe ^[2] ; Shunichi,Sugawara ^[4] ; Shunichiro,Iwasawa ^[5] ; Yoshio,Tsunezuka ^[6] ; Ou,Yamaguchi ^[7] ; Morihito,Okada ^[8] ; Kozo,Yoshimori ^[9] ; Ichiro,Nakachi ^[10] ; Akihiko,Gemma ^[11] ; Koichi,Azuma ^[12] ; Futoshi,Kurimoto ^[13] ; Yukari,Tsubata ^[14] ; Yuka,Fujita ^[15] ; Hiromi,Nagashima ^[16] ; Gyo,Asai ^[17] ; Satoshi,Watanabe ^[18] ; Masaki,Miyazaki ^[19] ; Koichi,Hagiwara ^[20] ; Toshihiro,Nukiwa ^[21] ; Satoshi,Morita ^[22] ; Kunihiko,Kobayashi ^[7] ; Makoto,Maemondo ^[23]

作者单位： Kanagawa Cancer Center, Yokohama, Japan. ^[1] Miyagi Cancer Center, Natori, Japan. ^[2] St Marianna University School of Medicine, Kawasaki, Japan. ^[3] Sendai Kousei Hospital, Sendai, Japan. ^[4] Chiba University, Chiba, Japan. ^[5] Ishikawa Prefectural Central Hospital, Kanazawa, Japan. ^[6] Saitama Medical University, Saitama, Japan. ^[7] Hiroshima University Hospital, Hiroshima, Japan. ^[8] Fukujuji Hospital, Tokyo, Japan. ^[9] Saiseikai Utsunomiya Hospital, Utsunomiya, Japan. ^[10] Nippon Medical School, Tokyo, Japan. ^[11] Kurume University, Kurume, Japan. ^[12] Saitama Cancer Center, Saitama, Japan. ^[13] Shimane University, Shimane, Japan. ^[14] National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan. ^[15] Iwate Medical University School of Medicine, Morioka, Japan. ^[16] Aichi Cancer Center Aichi Hospital, Okazaki, Japan. ^[17] Niigata University Medical and Dental Hospital, Niigata, Japan. ^[18] Suita Municipal Hospital, Osaka, Japan. ^[19] Jichi Medical University, Shimotsuke, Japan. ^[20] Tohoku University, Miyagi, Japan. ^[21] Kyoto University, Kyoto, Japan. ^[22] Iwate Medical University School of Medicine, Morioka, Japan. Electronic address: maemondo-ma693@aioros.ocn.ne.jp. ^[23]